The Influence of Age and Gender on the Pharmacokinetics of Moxifloxacin
Authors:
- 1 January 2001
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (Supplement) , 11-18
Abstract
Objective Moxifloxacin is a new 8-methoxyfluoroquinolone with a broad antibacterial spectrum. The purpose of the present study was to determine the effects of age and gender on pharmacokinetics,...Keywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics, Safety, and Tolerability of Ascending Single Doses of Moxifloxacin, a New 8-Methoxy Quinolone, Administered to Healthy SubjectsAntimicrobial Agents and Chemotherapy, 1998
- Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusingJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 1997
- In vitro Activity of BAY 12-8039, a New 8-MethoxyquinoloneChemotherapy, 1996
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection modelAntimicrobial Agents and Chemotherapy, 1993
- Drug Disposition in Old AgeNew England Journal of Medicine, 1982